Fulminate Hepatic Failure in a 5 Year Old Female after Inappropriate Acetaminophen Treatment

Irena Kasmi1, Sashenka Sallabanda1, Gentian Kasmi2

  • 1Pediatric Department University Hospital Center, Tirana, Albania.

Insights

Pediatric acetaminophen toxicity can cause severe liver failure and pancreatitis, even from unintentional overdoses. Early N-acetylcysteine (NAC) treatment is crucial for recovery in children with acetaminophen poisoning.

Area of Science:

  • Pediatric Toxicology
  • Hepatology
  • Clinical Pharmacology

Background:

  • Acetaminophen is a common pediatric medication, generally safe but with risks of toxicity from overdoses.
  • While less common than in adults, acetaminophen toxicity can occur in children due to intentional or unintentional supratherapeutic dosing.
  • This case highlights the potential for severe adverse events in pediatric patients receiving high doses of acetaminophen.

Observation:

  • A 5-year-old girl experienced fulminant liver failure, renal impairment, and acute pancreatitis from unintentional acetaminophen overdose (4800 mg over 3 days).
  • Clinical presentation included fever, jaundice, lethargy, encephalopathy, and significantly elevated liver enzymes (ALT 5794 UI/l, AST 6000 UI/l).
  • The patient also developed acute pancreatitis with markedly elevated amylase and lipase levels.

Findings:

  • Early administration of oral N-acetylcysteine (NAC) led to rapid improvement in liver enzymes, hepatic function, and encephalopathy.
  • Despite the severity of liver injury and pancreatitis, the child made a full recovery within 29 days.
  • Blood acetaminophen levels were 32 mg/l ten hours after the last dose, indicating significant ingestion.

Implications:

  • Healthcare providers must consider acetaminophen toxicity in pediatric patients presenting with liver failure, especially after recent drug administration.
  • Prompt initiation of N-acetylcysteine (NAC) is vital when acetaminophen toxicity is suspected, continuing treatment until hepatic function normalizes.
  • This case underscores the importance of careful dosing and monitoring of acetaminophen in children to prevent severe, potentially fatal, toxicity.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
995
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
120
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
652